Breast cancer outcomes: The crucial role of the breast surgeon in the era of personal genetics and systems biology

Annals of Surgery

Volumn 249, Issue 6, 2009, Pages 1067-1068

  Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TRASTUZUMAB;

BREAST CANCER; BREAST SURGERY; CANCER GENETICS; CANCER RISK; GENETIC PREDISPOSITION; GENETICS; HUMAN; LETTER; MEDICAL DECISION MAKING; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; SURGEON; SYSTEMS BIOLOGY; BREAST TUMOR; FEMALE; MASTECTOMY; NOTE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MASTECTOMY;

EID: 67649201897     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181a88b69     Document Type: Letter

References (14)

1. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133-1144.
2. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26:4360-4361.
3. Roukos DH. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009;360:1362.
4. Fatouros M, Baltoyiannis G, Roukos DH. The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations. Ann Surg Oncol. 2008;15:21-33.
5. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8:587-597.
6. Zork NM, Komenaka IK, Pennington RE Jr., Bowling MW, Norton LE, Clare SE, Goulet RJ Jr. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer. Ann Surg. 2008;248:280-5.
7. Donnelly P. Progress and challenges in genomewide association studies in humans. Nature. 2008;456:728-731.
8. Roukos DH. Personal Genomics and Genome-Wide Association Studies: Novel Discoveries but Limitations for Practical Personalized Medicine. Ann Surg Oncol. 2009;16:772-773.
9. Roukos DH. Assessing both genetic variation (SNPs/CNVs) and interactions with the environment may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9:1-6.
10. Roukos DH. Twenty-One-Gene Assay: Challenges and Promises in Translating Personal Genomics and Whole-Genome Scans Into Personalized Treatment of Breast Cancer. J Clin Oncol. 2009 Feb 2. [Epub ahead of print], DOI: 10.1200/JCO.2008.20.2812.
11. Rockman MV. Reverse engineering the genotype phenotype map with natural genetic variation. Nature. 2008;456:738-744.
12. Smith EN, Kruglyak L. Gene-environment interaction in yeast gene expression. PLoS Biol. 2008 Apr 15;6:e83.
13. Roukos DH. Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn. 2009;9:227-229.
14. Roukos DH. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn. 2009;9:217-221.